Novo Nordisk A/S NOVA.F Open Novo Nordisk A/S in new tab
Novo Nordisk A/S Analysis (NOVA.F)
Is Novo Nordisk A/S a good investment? Novo Nordisk A/S (NOVA.F) is currently trading at 38.20 EUR. Market analysts have a consensus price target of 116.88 EUR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 10.41. This relatively low multiple may signal that Novo Nordisk A/S is undervalued compared to historical market norms.
Earnings Schedule: Novo Nordisk A/S is expected to release its next earnings report on Aug. 7, 2024. The market consensus estimate for Forward EPS is 3.43.
For income investors, Novo Nordisk A/S pays a dividend yield of 4.29%. With a payout ratio of 50%, the dividend appears sustainable.
Investor FAQ
Does Novo Nordisk A/S pay a dividend?
Yes, it pays an annual dividend of 1.54 EUR (4.29% yield).
What asset class is Novo Nordisk A/S?
Novo Nordisk A/S is classified as a Stock. You can compare it against 7 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Aug. 7, 2024. The company currently has a trailing EPS of 3.67.
Company Profile
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Dividend Yield
4.29% (5y avg: 1.77%)
Annual Dividends
1.54 EUR
Next ex. div date
March 30, 2026
Payout Ratio
50.42%
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2027 | 1.30 EUR |
| March 22, 2027 (estimated) | 1.2973 |
| 2026 | 1.63 EUR |
| Aug. 17, 2026 (estimated) | 0.5970 |
| March 30, 2026 | 1.0345 |
| 2025 | 1.47 EUR |
| Aug. 18, 2025 | 0.4966 |
| March 31, 2025 | 0.9709 |
| 2024 | 2.56 EUR |
| Aug. 16, 2024 | 0.4393 |
| Aug. 15, 2024 | 0.4766 |
| March 22, 2024 | 0.7897 |
| March 21, 2024 | 0.8569 |
| 2023 | 1.82 EUR |
| Aug. 18, 2023 | 0.3724 |
| Aug. 17, 2023 | 0.4040 |
| March 24, 2023 | 0.5016 |
| March 23, 2023 | 0.5443 |
| 2022 | 1.42 EUR |
| Aug. 12, 2022 | 0.2455 |
| Aug. 11, 2022 | 0.2664 |
| March 25, 2022 | 0.4344 |
| March 24, 2022 | 0.4714 |
| 2021 | 1.30 EUR |
| Aug. 16, 2021 | 0.2338 |
| Aug. 15, 2021 | 0.2537 |
| March 26, 2021 | 0.3918 |
| March 25, 2021 | 0.4251 |
| 2020 | 1.15 EUR |
| Aug. 14, 2020 | 0.2200 |
| Aug. 13, 2020 | 0.2387 |
| March 27, 2020 | 0.3325 |
| March 26, 2020 | 0.3608 |
| 2019 | 1.08 EUR |
| Aug. 16, 2019 | 0.1892 |
| Aug. 15, 2019 | 0.2053 |
| March 22, 2019 | 0.3302 |
| March 21, 2019 | 0.3582 |
| 2018 | 1.12 EUR |
| Aug. 17, 2018 | 0.1964 |
| Aug. 16, 2018 | 0.2132 |
| March 23, 2018 | 0.3425 |
| March 22, 2018 | 0.3716 |
| 2017 | 1.01 EUR |
| Aug. 17, 2017 | 0.2013 |
| Aug. 16, 2017 | 0.2185 |
| March 23, 2017 | 0.2848 |
| March 22, 2017 | 0.3091 |
| 2016 | 1.25 EUR |
| Aug. 11, 2016 | 0.1927 |
| Aug. 10, 2016 | 0.2091 |
| March 18, 2016 | 0.4071 |
| March 17, 2016 | 0.4418 |
| 2015 | 0.65 EUR |
| March 19, 2015 | 0.3102 |
| March 18, 2015 | 0.3366 |
| 2014 | 0.74 EUR |
| March 21, 2014 | 0.3528 |
| March 20, 2014 | 0.3828 |
| 2013 | 0.56 EUR |
| March 21, 2013 | 0.2636 |
| March 20, 2013 | 0.2936 |
| 2012 | 0.44 EUR |
| March 22, 2012 | 0.2133 |
| March 21, 2012 | 0.2314 |
| 2011 | 0.32 EUR |
| March 24, 2011 | 0.1545 |
| March 23, 2011 | 0.1676 |
Yearly aggregated dividends
Dividends
|
Novo Nordisk A/S
Mar 30, 2026 Paid
Dividend
1.034526 EUR |
|
Novo Nordisk A/S
Aug 18, 2025 Paid
Dividend
0.496555 EUR |
Historical Split Corporate Actions
| Split Date | Split Ratio to 1 |
|---|---|
| Jan. 9, 2014 | 5.000000 |
| Sept. 20, 2023 | 2.000000 |
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion